Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheuerle

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Medical Research|July 25, 1996
Association of the LHON 13,708 and 15,257 mitochondrial DNA mutations with neurodegenerative diseases distinct from LHONG Rödel, R Laubhan, A Scheuerle, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2008
[Endophthalmitis after repeated bevacizumab injections]K B Schaal, A E Höh, A Scheuerle, et al.
Versicherungsmedizin|January 7, 2015
[The histological confirmation of diffuse axonal injury in severe brain injury survivors]D Woischneck, T Kapapa, A Scheuerle, et al.
American Journal of Human Genetics|December 1, 1994
De novo mutation in three families with multigenerational incontinentia pigmentiA Scheuerle, R A Lewis, M L Levy, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 27, 2008
[Intravitreal anti-VEGF therapy with bevacizumab for neovascular AMD]K B Schaal, C Engler, F Schütt, et al.
Biochimie|December 4, 2012
Aldehyde dehydrogenase and HSP90 co-localize in human glioblastoma biopsy cellsF Rappa, F Cappello, M-E Halatsch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 19, 2008
[OCT-based re-injections for anti-VEGF-treatment for neovascular ARMD]K B Schaal, A E Höh, A Scheuerle, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|May 20, 2008
[OCT-guided reinjection of 2.5 mg bevacizumab for treating macular edema due to retinal vein occlusion]A E Höh, K B Schaal, A Scheuerle, et al.
Clinical Neuropathology|April 30, 1998
Disseminated neocortical and subcortical encephalopathy (DNSE) with widespread activation of brain macrophages: a new dementia disorder? Autopsy reports of two postmenopausal women from families with mitochondrial DNA mutationsO Haferkamp, W Rosenau, A Scheuerle, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|March 21, 2007
[Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion]K B Schaal, A E Höh, A Scheuerle, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Medical Research|July 25, 1996
Association of the LHON 13,708 and 15,257 mitochondrial DNA mutations with neurodegenerative diseases distinct from LHONG Rödel, R Laubhan, A Scheuerle, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2008
[Endophthalmitis after repeated bevacizumab injections]K B Schaal, A E Höh, A Scheuerle, et al.
Versicherungsmedizin|January 7, 2015
[The histological confirmation of diffuse axonal injury in severe brain injury survivors]D Woischneck, T Kapapa, A Scheuerle, et al.
American Journal of Human Genetics|December 1, 1994
De novo mutation in three families with multigenerational incontinentia pigmentiA Scheuerle, R A Lewis, M L Levy, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 27, 2008
[Intravitreal anti-VEGF therapy with bevacizumab for neovascular AMD]K B Schaal, C Engler, F Schütt, et al.
Biochimie|December 4, 2012
Aldehyde dehydrogenase and HSP90 co-localize in human glioblastoma biopsy cellsF Rappa, F Cappello, M-E Halatsch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 19, 2008
[OCT-based re-injections for anti-VEGF-treatment for neovascular ARMD]K B Schaal, A E Höh, A Scheuerle, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|May 20, 2008
[OCT-guided reinjection of 2.5 mg bevacizumab for treating macular edema due to retinal vein occlusion]A E Höh, K B Schaal, A Scheuerle, et al.
Clinical Neuropathology|April 30, 1998
Disseminated neocortical and subcortical encephalopathy (DNSE) with widespread activation of brain macrophages: a new dementia disorder? Autopsy reports of two postmenopausal women from families with mitochondrial DNA mutationsO Haferkamp, W Rosenau, A Scheuerle, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|March 21, 2007
[Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion]K B Schaal, A E Höh, A Scheuerle, et al.
Pageof 3